Robert Olstein - Olstein Capital Management 13F Activity & Position Changes (Q1 2014)

According to the SEC 13F filed on Jul 07, 2026, the Olstein Capital Management portfolio showed several notable changes in holdings as of quarter-end Mar 31, 2014. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q1 2014, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q1 2014
A
Agilent Technologies, Inc.
Sell - Position Exit
-85,000
Q1 2014
AAPL
Apple Inc.
Buy
+1,000
Q1 2014
ABM
ABM Industries Incorporated
Buy
+14,900
Q1 2014
ABT
Abbott Laboratories
Buy
+3,000
Q1 2014
ADI
Analog Devices, Inc.
Sell - Position Exit
-100,000
Q1 2014
ALK
Alaska Air Group, Inc.
Sell
-14,000
Q1 2014
BAX
Baxter International Inc.
Sell
-9,000
Q1 2014
BDX
Becton, Dickinson and Company
Sell
-8,000
Q1 2014
BIG
Sell
-53,000
Q1 2014
BK
The Bank of New York Mellon Cor
Buy
+108,000
Q1 2014
CECO
CECO Environmental Corp.
Buy
+47,000
Q1 2014
CMCSA
Comcast Corporation
Buy
+38,000
Q1 2014
CMI
Cummins Inc.
Sell
-9,300
Q1 2014
CRL
Charles River Laboratories Inte
Sell
-88,000
Q1 2014
CTAS
Cintas Corporation
Sell
-7,000
Q1 2014
CVS
CVS Health Corporation
Buy - Position Entry
+92,000
Q1 2014
DAL
Delta Air Lines, Inc.
Sell
-41,000
Q1 2014
DDS
Dillard's, Inc.
Buy
+36,000
Q1 2014
DE
Deere & Company
Sell
-6,000
Q1 2014
DGX
Quest Diagnostics Incorporated
Buy
+7,000
Q1 2014
DIS
Walt Disney Company (The)
Sell
-14,900
Q1 2014
DOV
Dover Corporation
Sell - Position Exit
-29,900
Q1 2014
EBAY
eBay Inc.
Sell
-31,000
Q1 2014
EFX
Equifax, Inc.
Sell
-26,000
Q1 2014
ENTG
Entegris, Inc.
Sell
-55,400
Q1 2014
ETD
Ethan Allen Interiors Inc.
Buy
+38,000
Q1 2014
FITB
Fifth Third Bancorp
Buy - Position Entry
+223,000
Q1 2014
GLW
Corning Incorporated
Buy
+5,000
Q1 2014
GM
General Motors Company
Buy
+46,000
Q1 2014
HAE
Haemonetics Corporation
Buy - Position Entry
+14,400
Page 1 of 3